ES2323661T3 - Metodo de preparacion de una protesis vascular. - Google Patents
Metodo de preparacion de una protesis vascular. Download PDFInfo
- Publication number
- ES2323661T3 ES2323661T3 ES99927195T ES99927195T ES2323661T3 ES 2323661 T3 ES2323661 T3 ES 2323661T3 ES 99927195 T ES99927195 T ES 99927195T ES 99927195 T ES99927195 T ES 99927195T ES 2323661 T3 ES2323661 T3 ES 2323661T3
- Authority
- ES
- Spain
- Prior art keywords
- layers
- tissue
- icl
- cells
- prosthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 230000002792 vascular Effects 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 2
- 239000011159 matrix material Substances 0.000 claims abstract description 31
- 210000001519 tissue Anatomy 0.000 claims description 91
- 102000008186 Collagen Human genes 0.000 claims description 26
- 108010035532 Collagen Proteins 0.000 claims description 26
- 229920001436 collagen Polymers 0.000 claims description 26
- 238000004132 cross linking Methods 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- 210000000813 small intestine Anatomy 0.000 claims description 17
- 210000004876 tela submucosa Anatomy 0.000 claims description 15
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000003431 cross linking reagent Substances 0.000 claims description 13
- 230000018044 dehydration Effects 0.000 claims description 8
- 238000006297 dehydration reaction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 abstract description 47
- 230000008439 repair process Effects 0.000 abstract description 14
- 241001465754 Metazoa Species 0.000 abstract description 10
- 238000002513 implantation Methods 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 65
- 238000010276 construction Methods 0.000 description 48
- 239000000243 solution Substances 0.000 description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 21
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- 238000004140 cleaning Methods 0.000 description 17
- 210000000936 intestine Anatomy 0.000 description 17
- 238000003756 stirring Methods 0.000 description 14
- 239000007943 implant Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 210000000056 organ Anatomy 0.000 description 10
- 239000004417 polycarbonate Substances 0.000 description 10
- 229920000515 polycarbonate Polymers 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000282898 Sus scrofa Species 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 7
- 239000004744 fabric Substances 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000007634 remodeling Methods 0.000 description 7
- 206010019909 Hernia Diseases 0.000 description 6
- 241000594026 Rhodeus Species 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 210000005166 vasculature Anatomy 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000002308 calcification Effects 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006065 biodegradation reaction Methods 0.000 description 3
- 238000010382 chemical cross-linking Methods 0.000 description 3
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 210000004969 inflammatory cell Anatomy 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 210000001608 connective tissue cell Anatomy 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- KFDNQUWMBLVQNB-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical compound [Na].[Na].[Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KFDNQUWMBLVQNB-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 238000013382 DNA quantification Methods 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000013381 RNA quantification Methods 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- KEUKAQNPUBYCIC-UHFFFAOYSA-N ethaneperoxoic acid;hydrogen peroxide Chemical compound OO.CC(=O)OO KEUKAQNPUBYCIC-UHFFFAOYSA-N 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 210000000505 parietal peritoneum Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000001139 rectus abdominis Anatomy 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C53/00—Shaping by bending, folding, twisting, straightening or flattening; Apparatus therefor
- B29C53/36—Bending and joining, e.g. for making hollow articles
- B29C53/38—Bending and joining, e.g. for making hollow articles by bending sheets or strips at right angles to the longitudinal axis of the article being formed and joining the edges
- B29C53/40—Bending and joining, e.g. for making hollow articles by bending sheets or strips at right angles to the longitudinal axis of the article being formed and joining the edges for articles of definite length, i.e. discrete articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C53/00—Shaping by bending, folding, twisting, straightening or flattening; Apparatus therefor
- B29C53/56—Winding and joining, e.g. winding spirally
- B29C53/562—Winding and joining, e.g. winding spirally spirally
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8819898P | 1998-06-05 | 1998-06-05 | |
| US88198P | 1998-06-05 | ||
| US12054799P | 1999-02-17 | 1999-02-17 | |
| US120547P | 1999-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2323661T3 true ES2323661T3 (es) | 2009-07-22 |
Family
ID=26778405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99927195T Expired - Lifetime ES2323661T3 (es) | 1998-06-05 | 1999-06-04 | Metodo de preparacion de una protesis vascular. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7121999B2 (OSRAM) |
| EP (1) | EP1082071B1 (OSRAM) |
| JP (1) | JP4606583B2 (OSRAM) |
| AT (1) | ATE424164T1 (OSRAM) |
| AU (1) | AU754838B2 (OSRAM) |
| CA (1) | CA2334364C (OSRAM) |
| DE (1) | DE69940504D1 (OSRAM) |
| ES (1) | ES2323661T3 (OSRAM) |
| MX (1) | MXPA00012062A (OSRAM) |
| WO (1) | WO1999063051A2 (OSRAM) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6334872B1 (en) | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
| US20020095218A1 (en) | 1996-03-12 | 2002-07-18 | Carr Robert M. | Tissue repair fabric |
| ES2323099T3 (es) | 1998-06-05 | 2009-07-06 | Organogenesis Inc. | Protesis de injerto tubulares producidas por bioingenieria. |
| ATE424164T1 (de) | 1998-06-05 | 2009-03-15 | Organogenesis Inc | Verfahren zur herstellung einer gefässprothese |
| JP4341050B2 (ja) | 1998-06-05 | 2009-10-07 | オルガノジェネシス インク． | 生体工学により作成した血管移植片補綴 |
| US6773723B1 (en) * | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
| WO2002022184A2 (en) * | 2000-09-18 | 2002-03-21 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
| WO2003007879A2 (en) * | 2001-07-16 | 2003-01-30 | Depuy Products, Inc. | Cartilage repair and regeneration scaffold and method |
| DK1438081T3 (da) * | 2001-10-26 | 2008-07-07 | Cook Biotech Inc | Medicinsk transplantatanordning med mesh mönstret struktur |
| DE10249766A1 (de) | 2001-12-04 | 2003-07-10 | Matthias 99086 Erfurt Schreiber | Schichtgefässmatrix für den universellen Gewebeaufbau und Vorrichtung zur Inkubation |
| US20050283256A1 (en) * | 2004-02-09 | 2005-12-22 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
| US8765169B2 (en) | 2004-02-13 | 2014-07-01 | Smith & Nephew, Inc. | Wound healing profile |
| FR2870450B1 (fr) * | 2004-05-18 | 2007-04-20 | David Jean Marie Nocca | Bandelette prothesique ajustable |
| EP1827527B1 (en) * | 2004-12-06 | 2016-08-24 | Cook Incorporated | Inflatable occlusion devices, methods, and systems |
| US20060246033A1 (en) * | 2005-03-02 | 2006-11-02 | Cook Biotech Incorporated | Injectable bulking agent compositions |
| WO2006101885A2 (en) * | 2005-03-16 | 2006-09-28 | Musculoskeletal Transplant Foundation | Soft tissue processing |
| US20100112543A1 (en) * | 2005-03-16 | 2010-05-06 | Manh-Dan Ngo | Processing soft tissue, methods and compositions related thereto |
| CA2607913C (en) * | 2005-05-05 | 2014-03-18 | Cook Biotech Incorporated | Implantable materials and methods for inhibiting tissue adhesion formation |
| US8568761B2 (en) * | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
| US20070014869A1 (en) * | 2005-07-15 | 2007-01-18 | Cormatrix Cardiovascular, Inc. | Compositions for reconstruction, replacement or repair of intracardiac tissue |
| US7429241B2 (en) * | 2005-09-29 | 2008-09-30 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
| EP1948261B1 (en) * | 2005-10-18 | 2010-11-10 | Cook Biotech Incorporated | Medical device with affixation means |
| US20090209031A1 (en) * | 2006-01-26 | 2009-08-20 | Tyco Healthcare Group Lp | Medical device package |
| US9364215B2 (en) * | 2006-01-26 | 2016-06-14 | Covidien Lp | Medical device package |
| US20080097601A1 (en) * | 2006-07-31 | 2008-04-24 | Jeanne Codori-Hurff | Mastopexy and Breast Reconstruction Prostheses and Method |
| NZ612094A (en) * | 2006-10-06 | 2015-02-27 | Anthrogenesis Corp | Native (telopeptide) placental collagen compositions |
| CA2604433A1 (en) * | 2006-10-06 | 2008-04-06 | Tyco Healthcare Group Lp | Medical device package including self-puncturable port |
| US7614258B2 (en) | 2006-10-19 | 2009-11-10 | C.R. Bard, Inc. | Prosthetic repair fabric |
| US20100179639A1 (en) * | 2007-04-16 | 2010-07-15 | Stephen Bloor | Vascular implant |
| EP2178575A2 (en) * | 2007-04-16 | 2010-04-28 | Tissue Science Laboratories PLC | Methods and compositions for tissue regeneration |
| WO2008125858A2 (en) * | 2007-04-16 | 2008-10-23 | Tissue Science Laboratories Plc | Bone implant |
| DE102007037051A1 (de) * | 2007-07-24 | 2009-01-29 | Aesculap Ag | Flächiges Implantat |
| WO2009075786A1 (en) * | 2007-12-07 | 2009-06-18 | C.R. Bard, Inc. | Implantable prosthesis |
| US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
| US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
| WO2009086548A1 (en) * | 2007-12-31 | 2009-07-09 | C.R. Bard, Inc. | Vascular graft prosthesis with selective flow reduction |
| US9034002B2 (en) | 2008-02-18 | 2015-05-19 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US9393093B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
| EP2247245B1 (en) | 2008-02-18 | 2017-06-28 | Covidien LP | A device for deploying and attaching a patch to a biological tissue |
| US9833240B2 (en) | 2008-02-18 | 2017-12-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US9044235B2 (en) | 2008-02-18 | 2015-06-02 | Covidien Lp | Magnetic clip for implant deployment device |
| US9301826B2 (en) | 2008-02-18 | 2016-04-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US8808314B2 (en) | 2008-02-18 | 2014-08-19 | Covidien Lp | Device and method for deploying and attaching an implant to a biological tissue |
| US9393002B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
| US8317808B2 (en) | 2008-02-18 | 2012-11-27 | Covidien Lp | Device and method for rolling and inserting a prosthetic patch into a body cavity |
| US9398944B2 (en) | 2008-02-18 | 2016-07-26 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US8758373B2 (en) | 2008-02-18 | 2014-06-24 | Covidien Lp | Means and method for reversibly connecting a patch to a patch deployment device |
| AU2009201541B2 (en) * | 2008-04-23 | 2014-12-04 | Integra Lifesciences Corporation | Flowable collagen material for dural closure |
| US8709096B2 (en) | 2008-04-29 | 2014-04-29 | Proxy Biomedical Limited | Tissue repair implant |
| EP2792307B1 (en) | 2008-10-20 | 2017-10-04 | Covidien LP | A device for attaching a patch to a biological tissue |
| US8469779B1 (en) | 2009-01-02 | 2013-06-25 | Lifecell Corporation | Method for debristling animal skin |
| US20120010636A1 (en) * | 2009-02-11 | 2012-01-12 | Nanyang Technological University | Multi-layered surgical prosthesis |
| US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
| WO2011021082A1 (en) | 2009-08-17 | 2011-02-24 | PolyTouch Medical, Inc. | Means and method for reversibly connecting an implant to a deployment device |
| AU2010286117B9 (en) | 2009-08-17 | 2014-07-10 | Covidien Lp | Articulating patch deployment device and method of use |
| DE102010001271B8 (de) * | 2010-01-27 | 2012-12-06 | Urotiss Gmbh | Vernähbares Gewebetransplantatkonstrukt zur Rekonstruktion eines menschlichen oder tierischen Organs |
| EP2714099A4 (en) | 2011-05-27 | 2014-11-19 | Cormatrix Cardiovascular Inc | STERILIZED, ACELLULAR EXTRACELLULAR MATRIX COMPOSITIONS AND METHODS OF MAKING SAME |
| US9005275B2 (en) | 2011-11-18 | 2015-04-14 | Mayo Foundation For Medical Education And Research | Methods for replacing a circumferential segment of an esophagus |
| US9549805B2 (en) | 2011-12-20 | 2017-01-24 | Lifecell Corporation | Flowable tissue products |
| EP3549615B1 (en) | 2011-12-20 | 2020-12-16 | LifeCell Corporation | Sheet tissue products |
| ES2596522T3 (es) | 2012-01-13 | 2017-01-10 | Lifecell Corporation | Prótesis mamarias y métodos de fabricación de prótesis mamarias |
| AU2013212592B2 (en) | 2012-01-24 | 2016-06-30 | Lifecell Corporation | Elongated tissue matrices |
| EP3556320A1 (en) | 2012-06-21 | 2019-10-23 | LifeCell Corporation | Implantable prosthesis having acellular tissue attachments |
| WO2014058589A1 (en) * | 2012-10-08 | 2014-04-17 | Cormatrix Cardiovascular, Inc. | Multi-layer vascular prosthesis |
| ES2781578T3 (es) | 2013-02-06 | 2020-09-03 | Lifecell Corp | Métodos para la modificación localizada de productos tisulares |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| AU2016265286B2 (en) | 2015-05-15 | 2021-01-21 | Lifecell Corporation | Tissue matrices for plastic surgery |
| WO2017034952A1 (en) | 2015-08-21 | 2017-03-02 | Lifecell Corporation | Breast treatment device |
| EP3463500A1 (en) | 2016-06-03 | 2019-04-10 | LifeCell Corporation | Methods for localized modification of tissue products |
| EP3506854B1 (en) | 2016-08-31 | 2020-08-19 | LifeCell Corporation | Breast treatment device |
| CN107928837B (zh) * | 2017-10-23 | 2023-06-13 | 上海利格泰生物科技股份有限公司 | 用于肩袖修复的部分可吸收补片及制造方法 |
| CN111417361B (zh) | 2017-12-01 | 2023-08-11 | C·R·巴德股份有限公司 | 用于定制的内径缩小的可调节的血管移植物及相关方法 |
| WO2020227095A1 (en) | 2019-05-03 | 2020-11-12 | Lifecell Corporation | Breast treatment device |
| CN115970061A (zh) * | 2023-01-31 | 2023-04-18 | 上海卓阮医疗科技有限公司 | 用于缺乏血供场景的生物材料及其制备方法和应用 |
| CN116617471B (zh) * | 2023-07-24 | 2023-10-13 | 成都贝施美医疗科技股份有限公司 | 一种具有双层结构的口腔胶原膜及其制备方法 |
| CN119564938B (zh) * | 2024-12-10 | 2025-09-23 | 卓阮医疗科技（苏州）有限公司 | 一种实现可控缓释的高载药量的抗菌生物补片的工艺 |
| CN119733107B (zh) * | 2024-12-10 | 2025-09-12 | 卓阮医疗科技（苏州）有限公司 | 一种抗感染生物补片在腹腔开放临时关腹材料中的应用 |
| CN119564935A (zh) * | 2024-12-10 | 2025-03-07 | 卓阮医疗科技（苏州）有限公司 | 一种高封装药量抗菌缓释型生物补片 |
Family Cites Families (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2127903A (en) | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
| FR1358465A (fr) | 1963-02-21 | 1964-04-17 | Procédé de traitement de tissus animaux, en particulier en vue de la séparation de polysaccharides | |
| US3272204A (en) | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
| AT261800B (de) | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen |
| US3551560A (en) | 1967-10-02 | 1970-12-29 | Heinrich F Thiele | Process of reconstructing tendons,cartilage,nerve sheaths,and products |
| JPS4928193Y1 (OSRAM) | 1968-08-05 | 1974-08-01 | ||
| US3919411A (en) | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
| US3974526A (en) | 1973-07-06 | 1976-08-17 | Dardik Irving I | Vascular prostheses and process for producing the same |
| US3914802A (en) | 1974-05-23 | 1975-10-28 | Ebert Michael | Non-thrombogenic prosthetic material |
| US4148664A (en) | 1976-05-10 | 1979-04-10 | Avicon, Inc. | Preparation of fibrous collagen product having hemostatic and wound sealing properties |
| US4082507A (en) | 1976-05-10 | 1978-04-04 | Sawyer Philip Nicholas | Prosthesis and method for making the same |
| DE2960875D1 (en) | 1978-04-19 | 1981-12-10 | Ici Plc | A method of preparing a tubular product by electrostatic spinning |
| AU516741B2 (en) | 1978-05-23 | 1981-06-18 | Bio Nova Neo Technics Pty. Ltd. | Vascular prostheses |
| US4252759A (en) | 1979-04-11 | 1981-02-24 | Massachusetts Institute Of Technology | Cross flow filtration molding method |
| JPS6034450B2 (ja) | 1979-11-27 | 1985-08-08 | 北辰工業株式会社 | ゴムベルトの製造法 |
| US4378224A (en) | 1980-09-19 | 1983-03-29 | Nimni Marcel E | Coating for bioprosthetic device and method of making same |
| DE3042860A1 (de) | 1980-11-13 | 1982-06-09 | Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin | Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin |
| US4539716A (en) | 1981-03-19 | 1985-09-10 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
| US4420339A (en) | 1981-03-27 | 1983-12-13 | Kureha Kagaku Kogyo Kabushiki Kaisha | Collagen fibers for use in medical treatments |
| US4475972A (en) | 1981-10-01 | 1984-10-09 | Ontario Research Foundation | Implantable material |
| US4902289A (en) | 1982-04-19 | 1990-02-20 | Massachusetts Institute Of Technology | Multilayer bioreplaceable blood vessel prosthesis |
| US4787900A (en) | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
| US4502159A (en) | 1982-08-12 | 1985-03-05 | Shiley Incorporated | Tubular prostheses prepared from pericardial tissue |
| JPS59177042A (ja) | 1983-03-29 | 1984-10-06 | マ−セル・イ−・ニムニ | 生物学的補綴具のための皮膜及びその製造方法 |
| US4801299A (en) | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
| US5197977A (en) | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
| US5108424A (en) | 1984-01-30 | 1992-04-28 | Meadox Medicals, Inc. | Collagen-impregnated dacron graft |
| IL74180A (en) | 1984-01-30 | 1992-06-21 | Meadox Medicals Inc | Drug delivery collagen-impregnated synthetic vascular graft |
| US4842575A (en) | 1984-01-30 | 1989-06-27 | Meadox Medicals, Inc. | Method for forming impregnated synthetic vascular grafts |
| FR2559666B1 (fr) | 1984-02-21 | 1986-08-08 | Tech Cuir Centre | Procede de fabrication de tubes de collagene, notamment de tubes de faibles diametres, et application des tubes obtenus dans le domaine des protheses vasculaires et des sutures nerveuses |
| MX163953B (es) | 1984-03-27 | 1992-07-03 | Univ New Jersey Med | Procedimiento para preparar una matriz biodegradable a base de colageno |
| GB8413319D0 (en) | 1984-05-24 | 1984-06-27 | Oliver Roy Frederick | Biological material |
| US4889120A (en) | 1984-11-13 | 1989-12-26 | Gordon Robert T | Method for the connection of biological structures |
| US5037377A (en) | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
| US4629458A (en) | 1985-02-26 | 1986-12-16 | Cordis Corporation | Reinforcing structure for cardiovascular graft |
| US4755593A (en) | 1985-07-24 | 1988-07-05 | Lauren Mark D | Novel biomaterial of cross-linked peritoneal tissue |
| IL76079A (en) | 1985-08-13 | 1991-03-10 | Univ Ramot | Collagen implants |
| CA1292597C (en) | 1985-12-24 | 1991-12-03 | Koichi Okita | Tubular prothesis having a composite structure |
| DE3608158A1 (de) | 1986-03-12 | 1987-09-17 | Braun Melsungen Ag | Mit vernetzter gelatine impraegnierte gefaessprothese und verfahren zu ihrer herstellung |
| US5336256A (en) | 1986-04-17 | 1994-08-09 | Uab Research Foundation | Elastomeric polypeptides as vascular prosthetic materials |
| US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
| US5510254A (en) | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
| FR2612939B1 (fr) | 1987-03-26 | 1989-06-23 | Cird | Equivalent de peau |
| US5061276A (en) | 1987-04-28 | 1991-10-29 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
| US5007934A (en) | 1987-07-20 | 1991-04-16 | Regen Corporation | Prosthetic meniscus |
| US5263984A (en) | 1987-07-20 | 1993-11-23 | Regen Biologics, Inc. | Prosthetic ligaments |
| US5131908A (en) | 1987-09-01 | 1992-07-21 | Herbert Dardik | Tubular prosthesis for vascular reconstructive surgery and process for preparing same |
| US5263983A (en) | 1988-03-09 | 1993-11-23 | Terumo Kabushiki Kaisha | Medical material and prosthetic skin in which cells can invade |
| JPH0622579B2 (ja) | 1988-03-09 | 1994-03-30 | テルモ株式会社 | 細胞侵入性医用材料 |
| ATE109491T1 (de) | 1988-03-11 | 1994-08-15 | Chemokol G B R Ing Buero Fuer | Verfahren zur herstellung von kollagenmembranen für hämostase, wundbehandlung und implantate. |
| US5219576A (en) | 1988-06-30 | 1993-06-15 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
| US5024671A (en) | 1988-09-19 | 1991-06-18 | Baxter International Inc. | Microporous vascular graft |
| US4863668A (en) | 1988-09-22 | 1989-09-05 | University Of Utah | Method of forming fibrin-collagen nerve and body tissue repair material |
| US5026381A (en) | 1989-04-20 | 1991-06-25 | Colla-Tec, Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit |
| US4990158A (en) | 1989-05-10 | 1991-02-05 | United States Surgical Corporation | Synthetic semiabsorbable tubular prosthesis |
| US5084065A (en) | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
| ATE147613T1 (de) | 1989-09-15 | 1997-02-15 | Chiron Vision Corp | Synthetisches material, das die anlagerung, das wachstum und die befestigung von epithelzellen fördert, prosthetische vorrichtung zur subepithelialen implantation sowie behandelte linse |
| US5106949A (en) | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
| US5256418A (en) | 1990-04-06 | 1993-10-26 | Organogenesis, Inc. | Collagen constructs |
| US5378469A (en) | 1990-04-06 | 1995-01-03 | Organogenesis, Inc. | Collagen threads |
| US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
| CS277367B6 (en) | 1990-12-29 | 1993-01-13 | Krajicek Milan | Three-layered vascular prosthesis |
| WO1992014419A1 (en) | 1991-02-14 | 1992-09-03 | Baxter International Inc. | Pliable biological graft materials and their methods of manufacture |
| US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
| FR2679778B1 (fr) | 1991-08-02 | 1995-07-07 | Coletica | Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane. |
| FR2679788B1 (fr) | 1991-08-02 | 1994-03-18 | Thorel Jean Noel | Structures d'emulsions polyphasiques autostabilisees. |
| US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
| RU94028108A (ru) | 1991-11-26 | 1996-06-20 | Рисерч Дивелопмент Фаундейшн (US) | Трансплантант, способ восстановления функционирования нерва, способ замены кровеносного сосуда |
| US5376376A (en) | 1992-01-13 | 1994-12-27 | Li; Shu-Tung | Resorbable vascular wound dressings |
| JPH07509638A (ja) | 1992-08-07 | 1995-10-26 | ティーイーアイ バイオサイエンシズ，インコーポレイテッド | 細胞外マトリックスからの移植片組織の製造 |
| US5800537A (en) | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
| US5374515A (en) | 1992-11-13 | 1994-12-20 | Organogenesis, Inc. | In vitro cornea equivalent model |
| US5487895A (en) | 1993-08-13 | 1996-01-30 | Vitaphore Corporation | Method for forming controlled release polymeric substrate |
| US5523291A (en) | 1993-09-07 | 1996-06-04 | Datascope Investment Corp. | Injectable compositions for soft tissue augmentation |
| US5480424A (en) | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
| US5713950A (en) * | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
| US5460962A (en) | 1994-01-04 | 1995-10-24 | Organogenesis Inc. | Peracetic acid sterilization of collagen or collagenous tissue |
| US5571216A (en) | 1994-01-19 | 1996-11-05 | The General Hospital Corporation | Methods and apparatus for joining collagen-containing materials |
| US6334872B1 (en) | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
| DE69531859T2 (de) * | 1994-02-18 | 2004-07-29 | Organogenesis, Inc., Canton | Bioumbaubare collagentransplantat prothese |
| US5595571A (en) | 1994-04-18 | 1997-01-21 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
| CA2186374A1 (en) | 1994-04-29 | 1995-11-09 | William Carl Bruchman | Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same |
| CA2188563C (en) * | 1994-04-29 | 2005-08-02 | Andrew W. Buirge | Stent with collagen |
| CA2186375A1 (en) | 1994-04-29 | 1995-11-09 | William Carl Bruchman | Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix |
| DE69524501T2 (de) | 1994-08-12 | 2002-05-29 | Meadox Medicals, Inc. | Mit einen Heparin enhaltendes Kollagendichtmittel imprägniertes Gefässtransplantat |
| US5948654A (en) | 1996-08-28 | 1999-09-07 | Univ Minnesota | Magnetically oriented tissue-equivalent and biopolymer tubes comprising collagen |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US5618718A (en) | 1994-12-30 | 1997-04-08 | Universite Laval | Production of a contractile smooth muscle |
| US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
| US6106949A (en) * | 1995-04-06 | 2000-08-22 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Reformed polyimide fluorocarbon resin laminated film |
| US5711969A (en) | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
| US5554389A (en) | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
| US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
| EP0820301B1 (en) | 1995-04-07 | 2002-07-24 | Purdue Research Foundation | Tissue graft for urinary bladder reconstruction |
| US5788625A (en) | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
| JP3816534B2 (ja) | 1996-08-16 | 2006-08-30 | チルドレンズ メディカル センター コーポレーション | 細胞を接種された組織再建術用膀胱粘膜下組織 |
| SK22499A3 (en) * | 1996-08-23 | 1999-10-08 | Cook Biotech Inc | Graft prosthesis, materials and methods |
| ES2213835T3 (es) | 1996-09-16 | 2004-09-01 | Purdue Research Foundation | Injerto de tejidos intestinales submucosales para la reparacion de tejidos neurologicos. |
| AU722065B2 (en) | 1996-11-05 | 2000-07-20 | Purdue Research Foundation | Myocardial graft constructs |
| DE69720252T2 (de) | 1996-12-10 | 2003-12-04 | Purdue Research Foundation, West Lafayette | Gewebetransplantat aus der magensubmukosa |
| WO1998025546A1 (en) | 1996-12-10 | 1998-06-18 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
| WO1998025637A1 (en) | 1996-12-10 | 1998-06-18 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
| US6375989B1 (en) | 1996-12-10 | 2002-04-23 | Purdue Research Foundation | Submucosa extracts |
| CA2272097C (en) | 1996-12-10 | 2007-02-20 | Purdue Research Foundation | Artificial vascular valves |
| AU5520898A (en) | 1996-12-10 | 1998-07-03 | Purdue Research Foundation | Stent with reduced thrombogenicity |
| EP1021217A4 (en) | 1997-04-04 | 2000-09-27 | Cardio Tech Inc | TRANSMISSION SYSTEM FOR ADJUSTING HEART COMPRESSION |
| US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
| EP1011699B1 (en) | 1997-09-11 | 2001-12-05 | Purdue Research Foundation | Galactosidase modified submucosal tissue |
| DE19755116C1 (de) * | 1997-12-11 | 1999-03-04 | Dbb Fuel Cell Engines Gmbh | PEM-Brennstoffzellensystem sowie Verfahren zum Betreiben eines PEM-Brennstoffzellensystems |
| ATE424164T1 (de) | 1998-06-05 | 2009-03-15 | Organogenesis Inc | Verfahren zur herstellung einer gefässprothese |
| CA2334228C (en) | 1998-06-05 | 2010-09-28 | Organogenesis Inc. | Bioengineered vascular graft support prostheses |
| AU4316399A (en) | 1998-12-01 | 2000-06-19 | Cook Biotech, Inc. | A multi-formed collagenous biomaterial medical device |
| DE19856499C1 (de) * | 1998-12-08 | 2000-10-26 | Daimler Chrysler Ag | Verfahren und Vorrichtung zur zweistufigen Aufladung von Prozeßluft für eine Brennstoffzelle |
| WO2002022184A2 (en) | 2000-09-18 | 2002-03-21 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
-
1999
- 1999-06-04 AT AT99927195T patent/ATE424164T1/de not_active IP Right Cessation
- 1999-06-04 JP JP2000552247A patent/JP4606583B2/ja not_active Expired - Fee Related
- 1999-06-04 AU AU44163/99A patent/AU754838B2/en not_active Ceased
- 1999-06-04 MX MXPA00012062A patent/MXPA00012062A/es not_active IP Right Cessation
- 1999-06-04 CA CA2334364A patent/CA2334364C/en not_active Expired - Lifetime
- 1999-06-04 WO PCT/US1999/012400 patent/WO1999063051A2/en not_active Ceased
- 1999-06-04 ES ES99927195T patent/ES2323661T3/es not_active Expired - Lifetime
- 1999-06-04 EP EP99927195A patent/EP1082071B1/en not_active Expired - Lifetime
- 1999-06-04 DE DE69940504T patent/DE69940504D1/de not_active Expired - Lifetime
-
2003
- 2003-03-03 US US10/378,483 patent/US7121999B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU4416399A (en) | 1999-12-20 |
| JP4606583B2 (ja) | 2011-01-05 |
| JP2003527137A (ja) | 2003-09-16 |
| WO1999063051A3 (en) | 2000-01-27 |
| US7121999B2 (en) | 2006-10-17 |
| DE69940504D1 (OSRAM) | 2009-04-16 |
| ATE424164T1 (de) | 2009-03-15 |
| CA2334364C (en) | 2011-01-04 |
| CA2334364A1 (en) | 1999-12-09 |
| EP1082071A4 (en) | 2005-01-19 |
| EP1082071B1 (en) | 2009-03-04 |
| EP1082071A2 (en) | 2001-03-14 |
| AU754838B2 (en) | 2002-11-28 |
| MXPA00012062A (es) | 2003-04-22 |
| WO1999063051A2 (en) | 1999-12-09 |
| US20030130747A1 (en) | 2003-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2323661T3 (es) | Metodo de preparacion de una protesis vascular. | |
| ES2323099T3 (es) | Protesis de injerto tubulares producidas por bioingenieria. | |
| ES2323662T3 (es) | Protesis de injerto vascular producidas por bioingenieria. | |
| US9636435B2 (en) | Method for shaping tissue matrices | |
| EP2068766B1 (en) | Mastopexy and breast reconstruction prostheses | |
| AU763724B2 (en) | Bioengineered vascular graft support prostheses | |
| JP2012101100A (ja) | 過酢酸架橋非抗原性ｉｃｌ移植片 | |
| HK40018681A (en) | Method for shaping tissue matrices | |
| MXPA97007655A (en) | Tej repair fabric |